Search - tctmd.com

Displaying 341 - 360 of 1037

Sort: Relevancy | Date

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Yael L. Maxwell

August 31, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Industry News

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

May 23, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

L.A. McKeown

May 22, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Daily News

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Caitlin E. Cox

April 18, 2019

Presentation ARCH 2019

Update on Dual Antiplatelet Therapy

Presenter: James B Hermiller

April 12, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation ARCH 2019

LAA Closure Patient Selection, Imaging and Anti-Thrombotic Therapy

Presenter: Steven J Yakubov

April 11, 2019

News Daily News

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

Yael L. Maxwell

April 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

Presentation SIF 2019

DAPT Duration and When to Switch to Antiplatelet Monotherapy Post PCI

Presenter: Michael A. Kutcher

March 28, 2019

Advertisement

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

What I Am Most Looking Forward to at TCT 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Update on Dual Antiplatelet Therapy

Update: Drug-Eluting Stents

LAA Closure Patient Selection, Imaging and Anti-Thrombotic Therapy

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

TCTMD’s Top 10 Most Popular Stories for March 2019

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

DAPT Duration and When to Switch to Antiplatelet Monotherapy Post PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content